A new questionnaire for gastroesophageal reflux disease.

PubWeight™: 3.14‹?› | Rank: Top 1%

🔗 View Article (PMID 8189759)

Published in Mayo Clin Proc on June 01, 1994

Authors

G R Locke1, N J Talley, A L Weaver, A R Zinsmeister

Author Affiliations

1: Division of Gastroenterology and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905.

Associated clinical trials:

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study | NCT02081404

Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease (GERDILOR) | NCT03467438

Articles citing this

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut (1999) 3.45

Prediction of Barrett's esophagus among men. Am J Gastroenterol (2013) 2.22

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16

Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci (1999) 1.98

Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol (2013) 1.80

Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut (2004) 1.60

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut (2002) 1.57

Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57

Relationship between history, laryngoscopy and esophagogastroduodenoscopy for diagnosis of laryngopharyngeal reflux in patients with typical GERD. Eur Arch Otorhinolaryngol (2011) 1.50

Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut (2004) 1.47

Quality of life measurement in gastrointestinal and liver disorders. Gut (2000) 1.44

Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans. Gastrointest Endosc (2014) 1.41

A randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett's esophagus screening in the community. Am J Gastroenterol (2014) 1.35

Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol (2013) 1.29

The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther (2009) 1.25

Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut (2005) 1.22

Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology (2006) 1.22

Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol (2004) 1.22

Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease. Gut Liver (2009) 1.21

Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci (2007) 1.20

Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med (2008) 1.18

The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut (2008) 1.18

Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol (2010) 1.18

Symptoms of aerophagia are common in patients on continuous positive airway pressure therapy and are related to the presence of nighttime gastroesophageal reflux. J Clin Sleep Med (2013) 1.17

Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol (2009) 1.17

A segregation analysis of Barrett's esophagus and associated adenocarcinomas. Cancer Epidemiol Biomarkers Prev (2010) 1.13

Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol (2013) 1.09

Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci (2001) 1.09

A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol (2013) 1.07

The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia (2009) 1.06

Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil (2011) 1.01

Diagnostic utility of reflux disease symptoms. Gut (2004) 0.99

Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol (2012) 0.98

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol (2015) 0.98

Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol (2007) 0.97

Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter (2008) 0.97

Impact of acid suppression on upper gastrointestinal pH and motility. Dig Dis Sci (2010) 0.95

Quality of life assessment in gastro-oesophageal reflux disease. Gut (2004) 0.94

Best practice in symptom assessment: a review. Gut (2004) 0.92

A technical review and clinical assessment of the wireless motility capsule. Gastroenterol Hepatol (N Y) (2011) 0.89

Self-reported halitosis and gastro-esophageal reflux disease in the general population. J Gen Intern Med (2008) 0.88

Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough (2010) 0.87

Applying data mining techniques in the development of a diagnostics questionnaire for GERD. Dig Dis Sci (2007) 0.87

Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology (2008) 0.86

Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity. Dig Dis Sci (2008) 0.86

Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc (2011) 0.85

Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol (2013) 0.84

Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung (2012) 0.84

Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group. J Neurogastroenterol Motil (2013) 0.84

Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population. Dig Dis Sci (2008) 0.83

Association between body mass index and erosive esophagitis: a meta-analysis. World J Gastroenterol (2012) 0.83

Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2011) 0.83

Frequency and risk factors for Barrett's esophagus in Taiwanese patients: a prospective study in a tertiary referral center. Dig Dis Sci (2009) 0.82

Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough (2009) 0.82

Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective Study. Gut Liver (2011) 0.82

Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther (2015) 0.82

Physicians and patients measure different dimension on assessment for gastroesophageal reflux disease-related symptoms [corrected]. J Neurogastroenterol Motil (2011) 0.81

Unsedated transnasal endoscopy with ultrathin endoscope as a screening tool for research studies. Laryngoscope (2012) 0.81

Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil (2013) 0.81

Use of the Montreal global definition as an assessment of quality of life in reflux disease. Dis Esophagus (2011) 0.81

Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil (2009) 0.80

Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD). Dig Dis Sci (2002) 0.80

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD). Iran J Pharm Res (2014) 0.80

Uninvestigated dyspepsia in Latin America: a population-based study. Dig Dis Sci (2006) 0.80

MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study. Clin Transl Gastroenterol (2014) 0.80

Dietary guideline adherence for gastroesophageal reflux disease. BMC Gastroenterol (2014) 0.79

A retrospective, case-control pilot study of the natural history of pediatric gastroesophageal reflux. Dig Dis Sci (2007) 0.78

Mechanism of Gastroesophageal Reflux in Obstructive Sleep Apnea: Airway Obstruction or Obesity? J Clin Sleep Med (2016) 0.78

Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterol J (2015) 0.78

Symptomatic gastroesophageal reflux in acutely hospitalized patients. Dig Dis Sci (1999) 0.78

Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res (2009) 0.78

Gastrointestinal symptoms in morbid obesity. Front Med (Lausanne) (2014) 0.78

Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study. World J Gastroenterol (2011) 0.77

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci (2014) 0.77

Quality of life and patient satisfaction 3 months and 3 years after laparoscopic Nissen's fundoplication. Saudi J Gastroenterol (2008) 0.77

Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil (2013) 0.76

Impact of PPIs on patient focused symptomatology in GERD. Ther Clin Risk Manag (2008) 0.76

Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors. Dig Dis Sci (2015) 0.76

Cigarette smoking is a modifiable risk factor for Barrett's oesophagus. United European Gastroenterol J (2013) 0.75

Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study. Dig Dis Sci (2014) 0.75

Ischemic heart disease, factor predisposing to Barrett's adenocarcinoma: A case control study. World J Gastrointest Pharmacol Ther (2014) 0.75

Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World J Gastroenterol (2017) 0.75

Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects. Dig Dis Sci (2016) 0.75

Gastroesophageal reflux disease in our asthma patients: the presence of dysphagia can influence pulmonary function. Multidiscip Respir Med (2012) 0.75

Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition? BMC Gastroenterol (2014) 0.75

Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm. Cancer Epidemiol Biomarkers Prev (2016) 0.75

Schizophrenia and gastroesophageal reflux symptoms. Indian J Psychiatry (2015) 0.75

The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population-based study. Aliment Pharmacol Ther (2013) 0.75

The suitability of the GERDyzer instrument in pH-test-proven laryngopharyngeal reflux patients. Medicine (Baltimore) (2016) 0.75

In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease. United European Gastroenterol J (2015) 0.75

Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One (2016) 0.75

Investigation of intra-esophageal air kinetics and esophageal sphincters in patients with total laryngectomy during esophageal speech. Eur Arch Otorhinolaryngol (2015) 0.75

Does CPAP treatment lead to gastroesophageal reflux in patients with moderate and severe OSA? Eur Arch Otorhinolaryngol (2016) 0.75

Total diet, individual meals, and their association with gastroesophageal reflux disease. Health Promot Perspect (2017) 0.75

Articles by these authors

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med (2000) 10.21

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84

A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60

Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc (2000) 4.45

The frequency of carpal tunnel syndrome in computer users at a medical facility. Neurology (2001) 4.44

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60

A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12

Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96

Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum (1997) 2.93

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82

Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81

Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73

Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67

Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67

Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol (1994) 2.59

Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52

Molecular evolution of inversions in Drosophila pseudoobscura: the amylase gene region. Proc Natl Acad Sci U S A (1991) 2.48

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38

Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36

Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35

Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35

Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33

Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32

Lung nodule enhancement at CT: multicenter study. Radiology (2000) 2.32

Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30

Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer (2000) 2.28

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17

Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review. BJU Int (2003) 2.17

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12

Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12

Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09

Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08

Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08

The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery. Anesthesiology (1993) 2.04

Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01

Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol (2012) 2.01

The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01

Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc (1995) 1.97

The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96

Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94

Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94

Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92

Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85

Lung nodule enhancement at CT: prospective findings. Radiology (1996) 1.85

Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85